OrganiGram Holdings Inc (OGI)
1.51
+0.01
(+0.67%)
USD |
NASDAQ |
Nov 29, 16:00
1.55
+0.04
(+2.65%)
After-Hours: 07:31
OrganiGram Holdings Enterprise Value: 97.97M for Nov. 29, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 29, 2024 | 97.97M |
| November 27, 2024 | 96.93M |
| November 26, 2024 | 93.82M |
| November 25, 2024 | 105.24M |
| November 22, 2024 | 99.01M |
| November 21, 2024 | 97.97M |
| November 20, 2024 | 94.86M |
| November 19, 2024 | 91.74M |
| November 18, 2024 | 94.86M |
| November 15, 2024 | 90.70M |
| November 14, 2024 | 96.93M |
| November 13, 2024 | 105.24M |
| November 12, 2024 | 106.28M |
| November 11, 2024 | 103.16M |
| November 08, 2024 | 105.24M |
| November 07, 2024 | 112.50M |
| November 06, 2024 | 115.62M |
| November 05, 2024 | 133.26M |
| November 04, 2024 | 128.07M |
| November 01, 2024 | 120.81M |
| October 31, 2024 | 118.73M |
| October 30, 2024 | 126.00M |
| October 29, 2024 | 131.19M |
| October 28, 2024 | 136.38M |
| October 25, 2024 | 133.26M |
| Date | Value |
|---|---|
| October 24, 2024 | 127.04M |
| October 23, 2024 | 131.19M |
| October 22, 2024 | 134.30M |
| October 21, 2024 | 123.92M |
| October 18, 2024 | 126.00M |
| October 17, 2024 | 121.85M |
| October 16, 2024 | 121.85M |
| October 15, 2024 | 120.81M |
| October 14, 2024 | 124.96M |
| October 11, 2024 | 119.77M |
| October 10, 2024 | 113.54M |
| October 09, 2024 | 114.58M |
| October 08, 2024 | 117.69M |
| October 07, 2024 | 119.77M |
| October 04, 2024 | 123.92M |
| October 03, 2024 | 123.92M |
| October 02, 2024 | 121.85M |
| October 01, 2024 | 123.92M |
| September 30, 2024 | 129.11M |
| September 27, 2024 | 123.92M |
| September 26, 2024 | 124.96M |
| September 25, 2024 | 121.85M |
| September 24, 2024 | 128.07M |
| September 23, 2024 | 127.04M |
| September 20, 2024 | 128.07M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
41.66M
Minimum
Oct 26 2023
1.378B
Maximum
Feb 10 2021
302.22M
Average
250.78M
Median
Sep 10 2020
Enterprise Value Benchmarks
| Tilray Brands Inc | 1.258B |
| Aurinia Pharmaceuticals Inc | 919.82M |
| Edesa Biotech Inc | 5.885M |
| Lexaria Bioscience Corp | 29.37M |
| Xenon Pharmaceuticals Inc | 2.596B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.059M |
| Revenue (Quarterly) | 30.00M |
| Total Expenses (Quarterly) | 33.69M |
| EPS Diluted (Quarterly) | 0.019 |
| Gross Profit Margin (Quarterly) | 34.12% |
| Profit Margin (Quarterly) | 6.86% |
| Earnings Yield | -55.76% |
| Normalized Earnings Yield | 58.82 |